通过专为投资者打造的一站式数据看板，全面查看 Spyre Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

7.90B

股息TTM

0.00

市盈率 TTM

-35.57

每股收益TTM

-2.56

营业收入

0.00

净利润

-208.02M

净资产收益率

-42.63%

总资产收益率

-26.91%

Spyre Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

29.79%-0.43

-18.25%-0.88

18.30%-0.83

86.35%-0.19

28.99%-0.61

38.15%-0.74

74.71%-1.02

85.48%-1.36

98.49%-0.86

75.42%-1.20

18.43%-4.02

---9.34

---56.79

---4.89

---4.93

---20.17

----

营业收入

----

--0.00

-100.00%0.00

10.08%688.00K

-85.46%198.00K

-95.39%168.00K

-87.56%174.00K

-95.44%625.00K

--1.36M

--3.64M

--1.40M

净利润

1.41%-36.20M

-54.12%-69.00M

-11.07%-62.53M

83.80%-11.18M

5.46%-36.72M

-2.09%-44.77M

10.90%-56.30M

-72.11%-69.03M

82.11%-38.84M

-138.07%-43.86M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

7.94%-18.82M

10.21%-18.23M

-226.84%-22.32M

-34.13%-24.44M

9.99%-20.45M

-12.61%-20.31M

利润率

----

---31552.47%

---9304.04%

---11203.57%

---3007.54%

----

毛利率

----

--100.00%

----

资产负债率

----

-100.00%0.00%

--0.00%

--0.02%

--0.00%

----

利润表

营业收入

----

--0.00

-100.00%0.00

10.08%688.00K

-85.46%198.00K

-95.39%168.00K

-87.56%174.00K

-95.44%625.00K

--1.36M

--3.64M

--1.40M

营业利润

-57.19%-81.64M

-41.21%-75.64M

6.66%-57.17M

-2.70%-56.89M

-17.64%-51.94M

-12.13%-53.57M

-28.27%-61.25M

-66.62%-55.39M

-147.91%-44.15M

-154.04%-47.77M

-149.21%-47.75M

-77.25%-33.24M

20.58%-17.81M

23.06%-18.81M

6.26%-19.16M

7.58%-18.75M

-234.42%-22.42M

-34.22%-24.44M

10.25%-20.44M

-11.97%-20.29M

净利润

1.41%-36.20M

-54.12%-69.00M

-11.07%-62.53M

83.80%-11.18M

5.46%-36.72M

-2.09%-44.77M

10.90%-56.30M

-72.11%-69.03M

82.11%-38.84M

-138.07%-43.86M

-235.67%-63.18M

-119.96%-40.11M

-872.45%-217.08M

24.61%-18.42M

7.94%-18.82M

10.21%-18.23M

-226.84%-22.32M

-34.13%-24.44M

9.99%-20.45M

-12.61%-20.31M

资产负债表

流动资产

117.69%1.17B

34.08%763.95M

27.82%777.78M

19.84%504.60M

23.66%538.83M

16.93%569.77M

78.16%608.47M

104.46%421.08M

81.64%435.74M

998.08%487.27M

448.57%341.53M

150.49%205.95M

148.21%239.89M

-38.87%44.38M

-37.04%62.26M

-30.03%82.22M

-28.07%96.65M

-52.05%72.60M

-33.98%98.89M

-18.62%117.51M

流动负债总额

-23.79%63.30M

20.49%85.16M

8.56%58.69M

-19.58%46.27M

275.46%83.06M

65.07%70.68M

69.05%54.06M

28.23%57.54M

-90.47%22.12M

238.83%42.82M

118.19%31.98M

153.83%44.87M

1364.09%232.23M

-22.46%12.64M

-27.24%14.66M

-13.46%17.68M

-23.01%15.86M

-49.65%16.30M

22.51%20.14M

42.37%20.43M

总资产

117.69%1.17B

34.08%763.95M

27.82%777.78M

19.83%504.60M

23.57%538.83M

16.85%569.78M

77.99%608.48M

103.16%421.09M

79.06%436.07M

829.60%487.60M

380.52%341.86M

126.36%207.26M

128.22%243.53M

-36.93%52.45M

-35.28%71.14M

-29.05%91.57M

-27.40%106.71M

-49.17%83.17M

-31.98%109.93M

-17.07%129.06M

总负债

-13.48%71.86M

6.85%93.14M

-31.03%62.55M

-47.17%49.50M

34.66%83.06M

6.40%87.17M

23.73%90.68M

42.92%93.70M

-75.68%61.68M

335.76%81.93M

251.69%73.29M

173.05%65.56M

1024.50%253.57M

-12.61%18.80M

-19.80%20.84M

-11.00%24.01M

-19.34%22.55M

-46.03%21.51M

19.27%25.98M

39.38%26.98M

总权益

141.60%1.10B

39.00%670.81M

38.13%715.24M

39.01%455.10M

21.74%455.77M

18.96%482.61M

92.80%517.80M

131.04%327.39M

3826.71%374.38M

1105.50%405.67M

433.89%268.57M

109.76%141.70M

-111.94%-10.05M

-45.42%33.65M

-40.07%50.30M

-33.82%67.56M

-29.29%84.16M

-50.18%61.66M

-39.97%83.94M

-25.09%102.08M

现金流量表

经营净额

-50.07%-69.88M

-39.95%-57.37M

-19.84%-44.58M

-26.16%-37.12M

25.20%-46.56M

-43.63%-40.99M

-19.86%-37.20M

14.96%-29.42M

-274.02%-62.25M

-61.86%-28.54M

-71.09%-31.04M

-129.61%-34.60M

19.49%-16.64M

32.86%-17.63M

5.85%-18.14M

11.36%-15.07M

-1092.94%-20.67M

-34.48%-26.26M

-12.47%-19.27M

3.06%-17.00M

投资净额

-477.10%-297.90M

92855.74%56.58M

-45.07%-247.41M

-41.51%25.00M

165.55%79.00M

99.94%-61.00K

-383.51%-170.54M

143.78%42.74M

-1882.81%-120.52M

-691.34%-104.96M

-351.94%-35.27M

-691.74%-97.63M

801.33%6.76M

-31.09%17.75M

44.88%14.00M

185.60%16.50M

101.58%750.00K

176.98%25.76M

-66.24%9.66M

-0.12%5.78M

融资净额

59079.62%432.60M

9704.00%12.26M

38.66%312.81M

-136.33%-4.64M

103.06%731.00K

-99.93%125.00K

37.89%225.60M

201.99%12.78M

-99.83%360.00K

1721550.00%172.16M

2045175.00%163.61M

-9539.23%-12.53M

390.59%209.99M

-16.67%10.00K

-110.00%-8.00K

-111.37%-130.00K

22393.75%42.80M

-96.69%12.00K

-99.68%80.00K

343.02%1.14M

常见问题

Spyre Therapeutics Inc的流动资产是多少？



根据Spyre Therapeutics Inc的FY2025财报，流动资产为777.78M（同比变化27.82）。

Spyre Therapeutics Inc的总资产是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的总资产为777.78M（同比变化27.82）。

Spyre Therapeutics Inc的总负债是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的总负债为62.55M（同比变化-31.03）。

Spyre Therapeutics Inc的总权益是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的总权益为715.24M（同比变化38.13）。

Spyre Therapeutics Inc的净营业收入是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的净营业收入为-219.56M（同比变化-5.27）。

Spyre Therapeutics Inc的净投资是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的净投资为-143.47M（同比变化59.39）。

Spyre Therapeutics Inc的净融资是多少？



根据Spyre Therapeutics Inc的FY2025财报，Spyre Therapeutics Inc的净融资为309.02M（同比变化-24.79）。

Spyre Therapeutics Inc的每股收益（EPS）是多少？



根据Spyre Therapeutics Inc的FY2025财报，每股收益（EPS）为-2.42（同比变化45.22）。

Spyre Therapeutics Inc的净利润是多少？



根据Spyre Therapeutics Inc的FY2025财报，净利润为-155.20M（同比变化25.39）。

Spyre Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Spyre Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-33.69（同比变化70.76）。

Spyre Therapeutics Inc的资产回报率（ROA）是多少？



根据Spyre Therapeutics Inc的FY2025财报，资产回报率（ROA）为-22.39（同比变化48.85）。

Spyre Therapeutics Inc的营业利润是多少？



根据Spyre Therapeutics Inc的FY2025财报，营业利润为-219.56M（同比变化-5.27）。